402 tetanus cases and 37 deaths were reported across most of the United States under recent surveillance. The case count came from nearly all states and the District of Columbia. National incidence per million persons was slightly lower than in the preceding monitoring window.
Tetanus, caused by the neurotoxin of Clostridium tetani, remains rare but persistent. Surveillance data show that reported illness continues to occur despite long-standing use of tetanus toxoid–containing vaccines. The case fatality ratio in the compiled reports underscores that once clinical tetanus develops, outcomes can be severe, especially when intensive care and rapid antitoxin administration are delayed.
The modest decline in incidence suggests stable population protection through active immunization and booster doses, yet also highlights gaps in vaccine coverage and wound prophylaxis. Public health programs rely on herd immunity, immunologic memory, and timely postexposure prophylaxis to prevent toxin-mediated disease. Ongoing case reporting from nearly the entire country indicates that surveillance, vaccination, and clinical awareness remain necessary to limit preventable tetanus morbidity and mortality.
